For example, in the clinical management of head and neck squamous cell carcinoma (HNSCC), the levels of transforming growth factor-beta 3 (TGF-β3) protein were monitored as a biomarker for patient response to chemoradiation therapy (CRT). The gene discussed is TGFB3; the disease is head and neck squamous cell carcinoma.